English
The Phase I workshop of Sanrun Biology has passed the new version of veterinary drug GMP acceptance
2024.08.25
On January 18-19, 2022, the expert group for the GMP acceptance of veterinary drugs from the Shandong Provincial Animal Husbandry and Veterinary Bureau visited Shandong Sanrun Biotechnology Co., Ltd. to conduct on-site acceptance of the new version of veterinary drug GMP.
The on-site operation assessment of the oral liquid filling position was carried out, and the operators performed the operation correctly; the content of the content of the honeysuckle oral liquid (batch number 20210801) was extracted from the sample room for the quality inspection personnel to conduct the content determination operation assessment, the operation was correct, the record content was complete, and the calculation result was accurate.
The inspection team conducted acceptance inspection on newly established oral liquid (containing traditional Chinese medicine extract), granule, pellet (containing traditional Chinese medicine extract), traditional Chinese medicine extract (Artemisia annua extract, Forsythia suspensa extract, Scutellaria baicalensis extract, licorice extract, rhubarb extract, Salvia miltiorrhiza ketone extract, Salvia miltiorrhiza total phenolic acid extract) according to the requirements of the new version of veterinary drug GMP, and all items passed the Ministry of Agriculture's new version of veterinary drug GMP on-site inspection and acceptance smoothly in one go.
The acceptance report states: Shandong Sanrun Biotechnology Co., Ltd. has a sound organizational structure, clear functions, personnel structure and quality meet the requirements, personnel allocation meets the requirements; the environment and hygiene of the factory and workshop meet the prescribed standards; the layout of the factory area and production plant is reasonable, the area and space are suitable for the production process and scale, and full recognition is given to the planning, design, production, and construction of the company.
Our company will take the new version of veterinary drug GMP acceptance as an opportunity to implement the concept of high-quality development, and strictly follow the new version of veterinary drug GMP for production and quality management.
The future looks bright, looking forward to creating brilliance again! Shandong Sanrun Biotechnology Co., Ltd. will continue to accumulate strength, strive to build an excellent brand of veterinary medicine for win-win cooperation, contribute Sanrun's wisdom to the industry progress, and make unremitting efforts for the safety, health, and green development of China's animal husbandry.
Contact
Leave your information and we will contact you.